Skip to main content

Anticoagulation in Continuous Arteriovenous Hemofiltration

  • Chapter
Arteriovenous Hemofiltration

Abstract

Anticoagulation is as necessary for continuous arteriovenous hemofiltration (CAVH) as for pump-driven hemofiltration, in order to prevent clotting in the filter. The difference in anticoagulation between arteriovenous hemofiltration and conventional hemodialysis and hemofiltration results from the considerably lower blood-flow rate due to the absence of pumps and due to the longer duration of continuous treatment. Also, patients treated with CAVH to date usually suffered from an acute illness, and polytraumatized and surgical patients especially could not be endangered by unnecessarily high doses of heparin.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 84.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 109.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Barrowcliffe TW, Johnson EA, Eggleton CA, Kemball-Cook C, Thomas DP (1979) Anticoagulant activities of high and low molecular weight heparin fractions. Br J Haemetol 41: 573–583

    Article  CAS  Google Scholar 

  2. Bengtsson G, Olivesona R, Hook M, Riesenfeld J, Lindendahl U (1980) Interaction of lipoprotein lipase with native and modified heparin-like Polysaccharides. Biochem J 189: 625–633

    PubMed  CAS  Google Scholar 

  3. Carter CJ, Kelton JG, Hirsh J, Santos AV, Gent M (1982) The relationship between the hemorrhagic and antithrombotic properties of low molecular weight heparin in rabbits. Blood 59: 1239–1245

    PubMed  CAS  Google Scholar 

  4. Hirsh J, O’Sullivan EF, Gallus AS (1970) The activated thromboplastin time in the control of heparin treatment. Aust Ann Med 46: 334

    Google Scholar 

  5. Holmer E (1980) Anticoagulant properties of heparin and heparin fractions. Scand J Haematol Suppl 25: 25–39

    Google Scholar 

  6. Holmer E, Mattson C, Nilsson S (1982) Anticoagulant and antithrombotic effects of heparin and low molecular weight heparin fragment in rabbits. Thromb Res 25: 475–485

    Article  PubMed  CAS  Google Scholar 

  7. Köstering H (1981) Die Thromboembolien. Schattauer, Stuttgart

    Google Scholar 

  8. Kramer P (1982) Arterio-venöse Hämofiltration. Vandenhoeck and Ruprecht, Göttingen-Zürich, S 67–80

    Google Scholar 

  9. Kramer P, Schräder J, Bohnsack W, Grieben G, Grone HJ, Scheler F (1981) Continuous arteriovenous hemofiltration (CAVH): a new kidney replacement therapy. Proc Eur Dial Transplant Assoc 18: 743

    PubMed  CAS  Google Scholar 

  10. Schräder J, Köstering H, Kramer P, Scheler F (1982) Antithrombin III–Substitution bei dialysepflichtiger Niereninsuffizienz. Dtsch Med Wochenschr 107: 1847–1850

    Article  PubMed  Google Scholar 

  11. Schräder J, Bohnsack W, Kaiser H, Eisenhauer T, Kramer P, Köstering H (1982) Antikoagulation bei kontinuierlicher arterio-venöser Hämofiltration. In: Kramer P (Hrsg) Arterio-venöse Hämofiltration. Vandenhoeck und Ruprecht, Göttingen-Zürich, S 67–80

    Google Scholar 

  12. Schräder J, Rieger J, Müschen H, Stibbe W, Köstering H, Kramer P, Scheler F (1985) Anwendung von niedermolekularem Heparin bei Hämodialysepatienten. Klin Wochenschr 63: 49–55

    Article  PubMed  Google Scholar 

  13. Swartz RD (1981) Hemorrhage during high-risk hemodialysis. Using controlled heparinization. Nephron 28:65-6914. Teien AN (1979) Assay of heparin using factor Xa and a chromogenic substrate. In: Scully MF, Kakkar VV (eds) Chromogenic peptide substrates. Churchill Livingstone, Edinburgh, pp 196–205

    Google Scholar 

  14. Teien AN (1979) Assay of heparin using factor Xa and a chromogenic substrate. In: Scully MF, Kakkar VV (eds) Chromogenic peptide substrate. Churchill Livingstone, Edinburgh, pp 196–205

    Google Scholar 

  15. Vogel GE, Kopp KF (1978) The conflict between anticoagulation and hemostasis during hemodialysis. Int J Artif Organs 1: 181–186

    PubMed  CAS  Google Scholar 

  16. Witt I (1977) New methods for the analysis of coagulation using chromogenic substrates. De Gruyter, Berlin

    Google Scholar 

Download references

Authors

Editor information

Editors and Affiliations

Rights and permissions

Reprints and permissions

Copyright information

© 1985 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Schrader, J., Kaiser, H., Eisenhauer, T., Kramer, P., Köstering, H., Scheler, F. (1985). Anticoagulation in Continuous Arteriovenous Hemofiltration. In: Kramer, P. (eds) Arteriovenous Hemofiltration. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70370-6_10

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-70370-6_10

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-15317-7

  • Online ISBN: 978-3-642-70370-6

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics